Posts by Muana Minkoué
A multidisciplinary HUG team launches a new study of innovative radioligand therapy (RLT)
A new radioligand to treat glioblastoma and digestive tumors evaluated as a world first at the Geneva University Hospitals (HUG). RLT is a nuclear medicine-based approach that destroys malignant tumors through targeted irradiation. Its specificity lies in the use of a radioactive element embedded in a chemical compound designed to bind specifically to…
Read MoreTerapet receives EUR 1.68 Million Eurostars grant
Terapet announced the receipt of a non-dilutive grant totalling approximately EUR 1.68 Million from the European Commission through the Eurostars Program. Terapet SA, is a Geneva-based CERN spin-off supported by FONGIT, developing an innovative platform technology for imaging in nuclear medicine. The received grant is supported by Innosuisse – the Swiss Innovation Agency,…
Read MoreArtiria Medical, Planny and Algorized receive support from FIT
The three startups have received financial support from the Foundation for technological innovation (FIT). Artiria Medical gets a Tech Growth loan to treat strokes Artiria Medical, a leader in medical device innovation for neurovascular treatments, receives a CHF 500,000 Tech Growth Loan. Their unique deflectable wire technology, which significantly improves the accuracy and speed of…
Read MoreDopamine production is not behind vulnerability to cocaine abuse
A UNIGE team shows that our ability to produce dopamine – the «happiness hormone» – is not correlated with increased vulnerability to drugs. Why do some people who try drugs struggle with substance abuse while others don’t? This question has long puzzled scientists. A team from the University of Geneva (UNIGE) explored the…
Read MoreAgora Care celebrates 10’000 patients and a new collaboration with Caduceo
The Campus biotech startup, recruited over 10’000 patients on its Agora Care platform. This marks an inflection point of the acceleration of Agora Care patient recruitment from early pilot projects to extended recruitment in several large radiology and healthcare networks in Switzerland. Agora Care is developing a patient-centered platform for storage and communication…
Read MoreFONGIT Innovation Fund (FIF) awards funding to Geneva-based tech projects
A seed loan of CHF 100,000 has been granted to previous FIF Grant laureate and HUG spinoff HeroSupport. One grant of CHF 50,000 has been awarded to HUG project SmellRS. The FIF supports innovative technological startups and scale-ups at different stages of their journey with three types of financing options: the FIF Grant…
Read MoreArtiria Medical successfully secures USD 6 Million
Artiria Medical secures funding to complete its clinical studies in stroke in both Europe and the Us, following promising first in-human results and FDA clearance. The MedTech company, developing next-generation neuro-interventional products for stroke and aneurysms, successfully closed off a Series A2 round of USD 0.6 Million. Furthermore, they secured an additional USD…
Read MoreLeenaards Prize awarded to two CHUV research groups
The two Leenards scientific prizes were awarded to research groups led by CHUV researchers. Each year, the Leenards Foundation awards scientific prizes for projects combining basic and clinical research, carried out by research groups in the Lake Geneva region. For 2024, a total of nearly CHF 1.4 million has been awarded to the…
Read MoreNewBiologix announced a licensing agreement with Florabio AS
NewBiologix SA announced a licensing agreement with Florabio AS to genetically engineer their proprietary HEK293 cell line. NewBiologix’s innovative approach stands to replace the industry-standard transient transfection methods, offering a stable, more reliable, and scalable solution for biopharmaceutical companies developing gene therapies. Under the terms of the agreement, NewBiologix acquired rights to use…
Read MoreAktiia secures CHF 27 Million
The Neuchâtel-based startup secures CHF 27 Million (USD 30M) in funding from Khosla Ventures and Others. Aktiia mission to revolutionise blood pressure monitoring has gained momentum with the successful closing of our CHF 27 million (USD 30 million) funding round, which was led by Redalpine and included participation from an international investor syndicate…
Read More